HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Oxidation-specific biomarkers and risk of peripheral artery disease.

AbstractOBJECTIVES:
The goal of this study was to examine the prospective association between oxidation-specific biomarkers, primarily oxidized phospholipids (OxPL) on apolipoprotein B-100-containing lipoproteins (OxPL/apoB) and lipoprotein (a) [Lp(a)], and risk of peripheral artery disease (PAD). We examined, as secondary analyses, indirect measures of oxidized lipoproteins, including autoantibodies to malondialdehyde-modified low-density lipoprotein (MDA-LDL) and apolipoprotein B-100 immune complexes (ApoB-IC).
BACKGROUND:
Biomarkers to predict the development of PAD are lacking. OxPL circulate in plasma, are transported by Lp(a), and deposit in the vascular wall and induce local inflammation.
METHODS:
The study population included 2 parallel nested case-control studies of 143 men within the Health Professionals Follow-up Study (1994 to 2008) and 144 women within the Nurses' Health Study (1990 to 2010) with incident confirmed cases of clinically significant PAD, matched 1:3 to control subjects.
RESULTS:
Levels of OxPL/apoB were positively associated with risk of PAD in men and women: pooled relative risk: 1.37, 95% confidence interval: 1.19 to 1.58 for each 1-SD increase after adjusting age, smoking, fasting status, month of blood draw, lipids, body mass index, and other cardiovascular disease risk factors. Lp(a) was similarly associated with risk of PAD (pooled adjusted relative risk: 1.36; 95% confidence interval: 1.18 to 1.57 for each 1-SD increase). Autoantibodies to MDA-LDL and ApoB-IC were not consistently associated with risk of PAD.
CONCLUSIONS:
OxPL/apoB were positively associated with risk of PAD in men and women. The major lipoprotein carrier of OxPL, Lp(a), was also associated with risk of PAD, reinforcing the key role of OxPL in the pathophysiology of atherosclerosis mediated by Lp(a).
AuthorsMonica L Bertoia, Jennifer K Pai, Jun-Hee Lee, Adam Taleb, Michel M Joosten, Murray A Mittleman, Xiaohong Yang, Joseph L Witztum, Eric B Rimm, Sotirios Tsimikas, Kenneth J Mukamal
JournalJournal of the American College of Cardiology (J Am Coll Cardiol) Vol. 61 Issue 21 Pg. 2169-79 (May 28 2013) ISSN: 1558-3597 [Electronic] United States
PMID23541965 (Publication Type: Comparative Study, Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
CopyrightCopyright © 2013 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.
Chemical References
  • Apolipoprotein B-100
  • Apolipoproteins B
  • Biomarkers
  • Lipoprotein(a)
  • Lipoproteins, LDL
  • Phospholipids
Topics
  • Adult
  • Aged
  • Apolipoprotein B-100 (blood)
  • Apolipoproteins B (blood)
  • Biomarkers (blood)
  • Female
  • Follow-Up Studies
  • Humans
  • Lipoprotein(a) (blood)
  • Lipoproteins, LDL (blood)
  • Male
  • Middle Aged
  • Oxidation-Reduction
  • Peripheral Arterial Disease (blood)
  • Phospholipids (blood)
  • Prospective Studies
  • Risk Factors
  • Severity of Illness Index

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: